Come True Biomedical Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 10.658 million compared to TWD 6.782 million a year ago. Operating loss was TWD 3.747 million compared to TWD 7.828 million a year ago. Net loss was TWD 3.749 million compared to TWD 5.575 million a year ago. Basic loss per share was TWD 0.12 compared to TWD 0.18 a year ago. For the half year, sales was TWD 21.479 million compared to TWD 11.945 million a year ago. Operating loss was TWD 6.843 million compared to TWD 17.228 million a year ago. Net loss was TWD 5.740 million compared to TWD 19.755 million a year ago. Basic loss per share was TWD 0.18 compared to TWD 0.62 a year ago.